Researchers at the Mass General Cancer Center and the Massachusetts Institute of Technology have developed an artificial intelligence (AI) tool called Sybil that can detect early signs of lung cancer.
Sybil was found to be accurate in predicting whether a person will develop lung cancer in the next year 86% to 94% of the time. The Centers for Disease Control and Prevention recommends low-dose CT scans for adults at risk for lung cancer to screen for the disease annually, but the most skilled radiologist’s eye can’t spot everything, and Sybil was developed to help with early detection.
Although Sybil has not yet been approved by the Food and Drug Administration for use outside clinical trials, it could play a unique role in the early detection of lung cancer.
Article written by Berkeley Lovelace Jr., John Torres, M.D., Marina Kopf and Patrick Martin